|
Delayed
London S.E.
03:52:28 2026-09-08 EDT
|
5-day change | 1st Jan Change | ||
| 1,200.00 GBX | -4.00% |
|
-4.00% | +33.33% |
| 07-03 | WINNERS & LOSERS: RC365 jumps on partnership; Craneware slides | AN |
| 05-29 | WINNERS & LOSERS: CelLBxHealth jumps on AstraZeneca partnership | AN |
Company Valuation: Braime Group PLC
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 22.99 | 32.88 | 28.85 | 23.04 | 17.52 | 15.36 |
| Change | - | 43.01% | -12.26% | -20.13% | -23.96% | -12.33% |
| Enterprise Value (EV) 1 | 25.97 | 36.82 | 33.55 | 26.9 | 20.84 | 19.46 |
| Change | - | 41.77% | -8.86% | -19.83% | -22.52% | -6.66% |
| P/E | 24.8x | 48.7x | 11.1x | 9.18x | 6.63x | 4.78x |
| PBR | 1.34x | 2.04x | 1.58x | 0.99x | 0.65x | 0.52x |
| PEG | - | -2.5x | 0x | -0.5x | 25.13x | 0.3x |
| Capitalization / Revenue | 0.7x | 0.9x | 0.64x | 0.48x | 0.36x | 0.3x |
| EV / Revenue | 0.79x | 1.01x | 0.75x | 0.56x | 0.43x | 0.38x |
| EV / EBITDA | 11.4x | 9.14x | 6.08x | 5.26x | 4.1x | 3.83x |
| EV / EBIT | 21.1x | 12.5x | 7.88x | 7.21x | 5.35x | 4.9x |
| EV / FCF | 61.8x | -70.5x | -58x | 13.5x | 46.6x | -59.3x |
| FCF Yield | 1.62% | -1.42% | -1.72% | 7.38% | 2.15% | -1.69% |
| Dividend per Share 2 | 0.118 | 0.1245 | 0.1375 | 0.1475 | 0.1525 | 0.165 |
| Rate of return | 0.83% | 0.55% | 0.65% | 1.02% | 1.45% | 1.83% |
| EPS 2 | 0.5715 | 0.4618 | 1.922 | 1.579 | 1.583 | 1.885 |
| Distribution rate | 20.6% | 27% | 7.15% | 9.34% | 9.63% | 8.75% |
| Net sales 1 | 32.8 | 36.41 | 44.88 | 48.16 | 48.95 | 50.94 |
| EBITDA 1 | 2.275 | 4.029 | 5.515 | 5.119 | 5.083 | 5.083 |
| EBIT 1 | 1.233 | 2.957 | 4.257 | 3.729 | 3.899 | 3.969 |
| Net income 1 | 0.823 | 0.665 | 2.768 | 2.274 | 2.28 | 2.714 |
| Net Debt 1 | 2.978 | 3.937 | 4.706 | 3.861 | 3.324 | 4.095 |
| Reference price 2 | 14.20 | 22.50 | 21.30 | 14.50 | 10.50 | 9.00 |
| Nbr of stocks (in thousands) | 1,440 | 1,440 | 1,440 | 1,440 | 1,440 | 1,440 |
| Announcement Date | 5/26/21 | 5/20/22 | 5/22/23 | 5/9/24 | 5/21/25 | 5/18/26 |
1GBP in Million2GBP
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 31.53M | |
| 30.81x | 5.27x | 19.16x | 0.85% | 121B | |
| 27.18x | 5.01x | 17.55x | 2.21% | 36.36B | |
| 21.4x | 1.83x | 13.19x | 2.19% | 31.12B | |
| 30.13x | 4.02x | 15.19x | 0.11% | 29.63B | |
| 19.97x | 3.38x | 10.9x | 1.55% | 27.95B | |
| 21.3x | 3.09x | 13.33x | 1.1% | 25.98B | |
| 23.03x | 2.82x | 12.15x | 1.64% | 24.68B | |
| 26.02x | 3.27x | 15.98x | 1.74% | 24.09B | |
| 95.41x | 36.02x | 78.55x | 0.4% | 24.88B | |
| Average | 32.81x | 7.19x | 21.78x | 1.31% | 34.6B | |
| Weighted average by Cap. | 31.69x | 6.41x | 20.56x | 1.21% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- BMT Stock
- Valuation Braime Group PLC
Select your edition
All financial news and data tailored to specific country editions
